Response Biomedical Corp — Investor Relations & Filings

Response Biomedical Corp. specializes in developing, manufacturing, and marketing rapid, quantitative point-of-care (POC) diagnostic testing solutions. The company's flagship product is the RAMP® system (Rapid Assay Measurement Platform), which includes modular instruments like the RAMP 200 and associated high-quality immunoassays. The RAMP system is designed to deliver central lab-quality results in minutes, supporting faster triage and informed clinical decisions in acute care settings. Key diagnostic areas addressed include cardiovascular health (e.g., Troponin I, NT-proBNP), infectious disease, sepsis, and women's health. The platform emphasizes efficiency, accuracy, and reliability, helping to reduce turnaround times and improve patient outcomes globally.